FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Fentanyl Citrate; Ropivacaine Hydrochloride | .002 mg/1 mL; 2 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Glycopyrrolate | .2 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Glycopyrrolate | .2 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Hydromorphone Hydrochloride | .5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Hydromorphone Hydrochloride | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Hydromorphone Hydrochloride | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Hydromorphone Hydrochloride | 1 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Hydromorphone Hydrochloride | .2 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ketamine Hydrochloride | 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ketamine Hydrochloride | 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ketamine Hydrochloride | 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ketamine Hydrochloride | 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ketamine Hydrochloride | 50 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Ketamine Hydrochloride | 50 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Labetalol Hydrochloride | 5 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Lidocaine Hydrochloride | 20 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Lidocaine Hydrochloride | 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Lidocaine Hydrochloride | 20 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "SCA Pharmaceuticals, LLC(080545245)" | Lidocaine Hydrochloride Anhydrous | 10 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "Sincerus Florida, LLC(080105003)" | Magnesium Sulfate Heptahydrate | 2 g/50 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "Staska Pharmaceuticals, Inc.(099939403)" | Dexamethasone | 4 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "US Compounding, Inc.(607517146)" | Magnesium Hydroxide; Aluminum Hydroxide; Dimethicone; Lidocaine Hydrochloride | 17 g/1 mL; 17 g/1 mL; 1.7 g/1 mL; 5.7 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "US Compounding, Inc.(607517146)" | 62295-3119 | 62295-3119-1 | Methylprednisolone Acetate | 80 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-3121 | 62295-3121-7 | Methylprednisolone Acetate; Lidocaine Hydrochloride | 40 mg/1 mL; 10 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-3324 | 62295-3324-5 | Neostigmine Methylsulfate | 1 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-3284 | 62295-3284-7 | Betamethasone Sodium Phosphate; Betamethasone Acetate | 4 mg/1 mL; 3 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-3322 | 62295-3322-7 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-8235 | 62295-8235-1 | Promethazine | 25 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-3319 | 62295-3319-7 | Brompheniramine Maleate | 10 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-3323 | 62295-3323-7 | Succinylcholine Chloride | 20 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-2169 | 62295-2169-6 | Testosterone Cypionate; Testosterone Propionate | 200 mg/1 mL; 20 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-5013 | 62295-5013-3 | Tetracaine Hydrochloride; Racepinephrine Hydrochloride; Lidocaine Hydrochloride | 5 mg/1 mL; .5 mg/1 mL; 40 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-8236 | 62295-8236-3 | Tetracaine Hydrochloride; Racepinephrine Hydrochloride; Lidocaine Hydrochloride | 5 mg/1 mL; .5 mg/1 mL; 40 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-3208 | 62295-3208-7 | Triamcinolone Diacetate | 80 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-3205 | 62295-3205-7 | Triamcinolone Diacetate | 40 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-3206 | 62295-3206-2 | Triamcinolone Diacetate | 40 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-3060 | 62295-3060-5 | Diphenhydramine Hydrochloride; Magnesium Hydroxide; Aluminum Hydroxide; Dimethicone; Lidocaine Hydrochloride | .8 mg/1 mL; 13.4 mg/1 mL; 13.4 mg/1 mL; 1.34 mg/1 mL; 6.6 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-3084 | 62295-3084-7 | Ephedrine Sulfate | 5 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-3084 | 62295-3084-5 | Ephedrine Sulfate | 5 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-3325 | 62295-3325-5 | Glycopyrrolate | .2 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | 62295-3135 | 62295-3135-5 | Iohexol | 518 mg/1 mL | 2021-1 | valid | 2026-11-12 | ||
| "US Compounding, Inc.(607517146)" | Lidocaine Hydrochloride; Phenylephrine Hydrochloride | 10 mg/1 mL; 15 mg/1 mL | 2021-1 | source_no_ndc | 2026-11-12 | ||||
| "Wells Pharmacy, Inc(057193721)" | 70713-218 | 70713-218-06 | Phentolamine Mesylate; Papaverine Hydrochloride; Atropine | .4 mg/1 mL; 3.6 mg/1 mL; .04 mg/1 mL | 2021-1 | valid | 2026-11-12 |